3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
23
Breast Neoplasms
12
Prostatic Neoplasms
11
Triple Negative Breast Neoplasms
7
Fallopian Tube Neoplasms
7
Stomach Neoplasms
5
Neoplasm Metastasis
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Metastatic Castration-resistant Prostate Cancer
4
Fanconi Anemia, Complementation Group D1
4
Small Cell Lung Carcinoma
3
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Endometrial Neoplasms
2
Interventions
Gemcitabine
6
Irinotecan
4
130-nm albumin-bound paclitaxel
4
Cisplatin
3
Albumin-Bound Paclitaxel
3
napabucasin
2
Leucovorin
2
Imatinib Mesylate
2
Everolimus
2
Ascorbic Acid
2
spartalizumab
1
pralsetinib
1
pembrolizumab
1
dostarlimab
1
copanlisib
1
alectinib
1
Ramucirumab
1
Paclitaxel
1
NUC-1031
1
Levoleucovorin
1
KRN-330
1
HhAntag691
1
Fluorouracil
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Digestive System Neoplasms
×
olaparib
×
Clear all
No trials found.